BBNX — Beta Bionics, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1674632 ·
Last close
$14.72
Market Cap
$800.28M
52W High
$32.71
52W Low
$8.80
ADV30
1,120,258
Next earnings
2026-10-27

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 35,505,000 20,331,000 -26,609,000 -24,353,000 443,759,000 81,551,000 42,376,000
Jun 2026 32,013,000 18,902,000 -25,578,000 -23,403,000 292,387,000 44,318,000 36,021,000
Mar 2026 27,626,000 16,437,000 -24,271,000 -21,895,000 304,417,000 30,206,000 33,172,000
Dec 2025 32,121,000 18,944,000 -16,124,000 -13,466,000 328,743,000 31,576,000 41,133,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-59,368,000
Investing CF
$-64,650,000
Financing CF
$167,084,000
CapEx
$-6,594,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.84
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-439,588,000
Inventory
$22,971,000
Receivables
$23,747,000
ST Investments
$158,653,000
EBIT TTM
$-88,406,000
Pretax Income TTM
$-83,117,000
Interest Exp TTM
—
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$127,265,000
EBITDA
$-89,858,000
Free Cash Flow
$-40,097,752
Enterprise Value
$676,545,344
Total Cash
$240,204,000
Total Debt
$6,101,000
Shares Out
54,367,067
Trailing EPS
$-1.83
Book Value
$7.38
ROE
-23.9%
ROA
-15.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 100,251,000 -71,681,000 -73,200,000 328,743,000 41,133,000 287,610,000 -50,925,000
Dec 2024 65,124,000 -45,251,000 -54,756,000 149,645,000 395,005,000 -245,360,000 -48,273,000
Dec 2023 11,995,000 -35,850,000 -44,099,000 110,040,000 313,145,000 -203,105,000 -32,445,000
Dec 2022 179,000 -65,844,000 -64,751,000 35,527,000 205,561,000 -170,034,000 -60,208,000

TTM Snapshot

Revenues TTM
$119,013,000
NetIncome TTM
$-72,973,000
OpCashFlow TTM
—
Assets (Latest)
$292,387,000
Forward EPS
$-2.12

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $10.00 · spot: $14.33 · call volume: 116 · put volume: 10

Peers — same industry

TickerNameMarket CapLastDaily %
KIDS ORTHOPEDIATRICS CORP $820.13M $31.41 —
STVN Stevanato Group S.p.A. $759.94M $15.25 —
INMD InMode Ltd. $743.47M $12.92 —
BVS Bioventus Inc. $725.83M $10.60 —
AORT ARTIVION, INC. $891.39M $18.27 —

News headlines (Yahoo Finance, 1h cache)

BBNX & SENS Launch Eversense 365 Integration With iLet Bionic Pancreas
2026-11-17 15:01 · Yahoo
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
2026-11-16 21:13 · Yahoo
Beta Bio: 3 Key Takeaways for Long-Term Investors
2026-11-09 17:20 · Yahoo
Beta Bionics Announces Participation at Upcoming Investor Conferences
2026-11-03 12:30 · Yahoo
Beta Bionics, Inc. Q3 2026 Earnings Call Summary
2026-10-28 12:30 · Yahoo
Beta Bionics (BBNX) Q3 2026 Earnings Call Transcript
2026-10-28 05:43 · Yahoo
Beta Bionics Q3 Earnings Call Highlights
2026-10-28 00:04 · Yahoo
Beta Bionics, Inc. (BBNX) Reports Q3 Loss, Beats Revenue Estimates
2026-10-27 20:15 · Yahoo
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
2026-10-27 20:02 · Yahoo
Beta Bionics, Inc. (BBNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-10-20 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.